Ovarian cancer incidence (1989-1991) and mortality (1954-1993) in the Netherlands

被引:25
作者
Koper, NP
Kiemeney, LALM
Massuger, LFAG
Thomas, CMG
Schijf, CPT
Verbeek, ALM
机构
[1] UNIV NIJMEGEN HOSP,LAB ENDOCRINOL & REPROD,NL-6500 HB NIJMEGEN,NETHERLANDS
[2] UNIV NIJMEGEN,DEPT EPIDEMIOL,NIJMEGEN,NETHERLANDS
[3] IKO,CTR COMPREHENS CANC,NIJMEGEN,NETHERLANDS
关键词
D O I
10.1016/0029-7844(96)00198-6
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To examine ovarian cancer incidence and mortality in the Netherlands, and to relate trends in mortality to changes in parity and use of oral contraceptives. Methods: Age-standardized and age-specific incidence and mortality rates are presented using incidence data from the Netherlands Cancer Registry, 1989-1991, and mortality data from the Netherlands Central Bureau of Statistics, 1954-1993. Results: in the period 1989-1991, age-standardized incidence of ovarian cancer was 14.9 per 10(5) woman-years. The majority (89%) of these tumors had an epithelial origin. Two-thirds of all newly diagnosed ovarian cancers already showed extension to the pelvis or beyond at diagnosis. From the period 1954-1958 to 1969-1973, age-standardized mortality rates increased from 10.6 to 13.1 per 10(5) woman-years. Thereafter, a decline was noted to 11.4 per 10(5) woman-years in the period 1989-1993. Age-specific mortality rates showed a pattern of rising mortality in the elderly, whereas mortality in the younger age categories was declining. The number of live births has declined gradually, and oral contraceptive use has increased. Conclusion: Incidence of ovarian cancer is high in the Netherlands, but comparable to other countries in northwestern Europe and North America. Mortality rates are rising in the elderly and declining in the young. Further research is needed concerning the effects of oral contraceptives, fertility drugs, and hormone replacement therapy on the incidence and mortality of ovarian cancer.
引用
收藏
页码:387 / 393
页数:7
相关论文
共 43 条
  • [1] THE INCIDENCE OF OVARIAN-CANCER IN SWEDEN, 1960-1984
    ADAMI, HO
    BERGSTROM, R
    PERSSON, I
    SPAREN, P
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1990, 132 (03) : 446 - 452
  • [2] AVERETTE HE, 1995, CANCER, V76, P1096, DOI 10.1002/1097-0142(19950915)76:6<1096::AID-CNCR2820760626>3.0.CO
  • [3] 2-4
  • [4] AYIOMAMITIS A, 1989, OBSTET GYNECOL, V73, P1017
  • [5] IMPROVED PROGNOSIS OF OVARIAN-CANCER IN THE NETHERLANDS DURING THE PERIOD 1975-1985 - A REGISTRY-BASED STUDY
    BALVERTLOCHT, HR
    COEBERGH, JWW
    HOP, WCJ
    BROLMANN, HAM
    CROMMELIN, M
    VANWIJCK, DJAM
    VERHAGENTEULINGS, MTCIJ
    [J]. GYNECOLOGIC ONCOLOGY, 1991, 42 (01) : 3 - 8
  • [6] Bosman J M, 1983, Ned Tijdschr Geneeskd, V127, P900
  • [7] MONITORING AND PROJECTING CANCER INCIDENCE IN SAARLAND, GERMANY, BASED ON AGE-COHORT ANALYSES
    BRENNER, H
    ZIEGLER, H
    [J]. JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 1992, 46 (01) : 15 - 20
  • [8] CHANG J, 1994, LANCET, V343, P335
  • [9] COLEMAN MP, 1993, IARC PUBLICATION, V21
  • [10] *CTR BUR STAT, 1980, MORT CAUS DEATH 1950